Suppr超能文献

清醒犬中由α1和α2肾上腺素能受体介导的冠状动脉血管收缩

Coronary vasoconstriction mediated by alpha 1- and alpha 2-adrenoceptors in conscious dogs.

作者信息

Woodman O L, Vatner S F

出版信息

Am J Physiol. 1987 Aug;253(2 Pt 2):H388-93. doi: 10.1152/ajpheart.1987.253.2.H388.

Abstract

Coronary vasoconstriction was examined in response to the selective stimulation of alpha 1- and alpha 2-adrenoceptors in chronically instrumented conscious dogs. Norepinephrine (NE, 0.05 and 0.1 micrograms X kg-1 X min-1), a mixed alpha 1- to alpha 2-adrenoceptor agonist, phenylephrine (PE, 0.5 and 1.0 micrograms X kg-1 X min-1), a preferential alpha 1-adrenoceptor agonist, and B-HT 920 (1.0 micrograms X kg-1 X min-1), a preferential alpha 2-adrenoceptor agonist, were infused intravenously after ganglionic (hexamethonium, 30 mg/kg iv), beta-adrenoceptor (propranolol, 1.0 mg/kg iv), and muscarinic receptor (atropine methylbromide, 0.1 mg/kg iv) antagonism. Equipressor doses of the alpha-adrenoceptor agonists caused similar increases in calculated late diastolic coronary resistance (NE, 0.57 +/- 0.10 mmHg X ml-1 X min; PE, 0.61 +/- 0.13 mmHg X ml-1 X min; B-HT 920, 0.64 +/- 0.09 mmHg X ml-1 X min). Mechanically increasing aortic root pressure to levels similar to those observed in response to alpha-adrenoceptor stimulation did not increase coronary resistance. Preferential antagonism of alpha 1-adrenoceptors with prazosin (1 mg/kg iv) abolished the vasoconstrictor response to PE but had a lesser effect on the response to B-HT 920. Antagonism of alpha 2-adrenoceptors with rauwolscine (alpha-yohimbine, 0.1 mg/kg iv) abolished the vasoconstrictor response to B-HT 920 but had a lesser effect on the response to PE. The response to NE was reduced to a similar degree by either alpha 1- or alpha 2-adrenoceptor antagonism.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

在长期植入仪器的清醒犬中,研究了冠状动脉收缩对α1和α2肾上腺素能受体选择性刺激的反应。在进行神经节(六甲铵,30mg/kg静脉注射)、β肾上腺素能受体(普萘洛尔,1.0mg/kg静脉注射)和毒蕈碱受体(甲基溴化阿托品,0.1mg/kg静脉注射)拮抗后,静脉注射去甲肾上腺素(NE,0.05和0.1μg·kg-1·min-1),一种α1至α2肾上腺素能受体混合激动剂,苯肾上腺素(PE,0.5和1.0μg·kg-1·min-1),一种优先的α1肾上腺素能受体激动剂,以及B-HT 920(1.0μg·kg-1·min-1),一种优先的α2肾上腺素能受体激动剂。α肾上腺素能受体激动剂的等压剂量导致计算的舒张末期冠状动脉阻力有相似增加(NE,0.57±0.10mmHg·ml-1·min;PE,0.61±0.13mmHg·ml-1·min;B-HT 920,0.64±0.09mmHg·ml-1·min)。机械性地将主动脉根部压力升高至与α肾上腺素能受体刺激反应中观察到的水平相似,并未增加冠状动脉阻力。用哌唑嗪(1mg/kg静脉注射)优先拮抗α1肾上腺素能受体消除了对PE的血管收缩反应,但对B-HT 920反应的影响较小。用育亨宾(α-育亨宾,0.1mg/kg静脉注射)拮抗α2肾上腺素能受体消除了对B-HT 920的血管收缩反应,但对PE反应的影响较小。α1或α2肾上腺素能受体拮抗对NE反应的降低程度相似。(摘要截短至250字)

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验